| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 365 | 378 | 409 | 400 | 432 | 455 | 492 | 459 | 489 | 526 | 565 | 558 | 653 | 655 | 714 | 735 | 776 | 782 | 829 | 791 | 750 | 398 | 611 | 755 | 846 | 867 | 952 | 967 | 951 | 1,041 | 1,173 | 1,140 | 1,236 | 1,249 | 1,324 | 1,222 | 1,273 | 1,364 | 1,424 | 1,353 | 1,503 |
| Expenses | 326 | 344 | 360 | 358 | 392 | 402 | 426 | 406 | 425 | 473 | 502 | 502 | 597 | 607 | 640 | 657 | 676 | 675 | 702 | 684 | 659 | 486 | 575 | 648 | 698 | 728 | 774 | 787 | 768 | 842 | 898 | 874 | 946 | 963 | 997 | 925 | 955 | 1,037 | 1,092 | 1,028 | 1,126 |
| EBITDA | 39 | 34 | 49 | 42 | 40 | 54 | 66 | 53 | 64 | 53 | 63 | 56 | 56 | 49 | 74 | 79 | 101 | 107 | 127 | 107 | 92 | -87 | 36 | 107 | 148 | 139 | 179 | 180 | 182 | 200 | 275 | 266 | 290 | 286 | 327 | 297 | 318 | 327 | 332 | 325 | 377 |
| Operating Profit % | 10 % | 8 % | 11 % | 10 % | 8 % | 11 % | 13 % | 11 % | 12 % | 9 % | 10 % | 9 % | 8 % | 7 % | 10 % | 10 % | 12 % | 13 % | 15 % | 13 % | 11 % | -23 % | 4 % | 14 % | 17 % | 15 % | 18 % | 18 % | 18 % | 19 % | 21 % | 23 % | 23 % | 22 % | 24 % | 23 % | 23 % | 23 % | 22 % | 23 % | 24 % |
| Depreciation | 19 | 18 | 18 | 19 | 21 | 19 | 20 | 20 | 21 | 22 | 29 | 24 | 26 | 33 | 34 | 35 | 36 | 41 | 43 | 46 | 55 | 46 | 46 | 47 | 45 | 45 | 46 | 46 | 47 | 48 | 49 | 57 | 56 | 59 | 55 | 63 | 65 | 62 | 65 | 70 | 83 |
| Interest | 12 | 9 | 8 | 6 | 6 | 6 | 5 | 6 | 6 | 10 | 8 | 8 | 21 | 17 | 18 | 18 | 18 | 22 | 22 | 21 | 21 | 20 | 19 | 19 | 18 | 17 | 17 | 16 | 16 | 15 | 15 | 19 | 21 | 21 | 23 | 25 | 28 | 34 | 35 | 37 | 41 |
| Profit Before Tax | 10 | 10 | 26 | 20 | 13 | 29 | 41 | 28 | 37 | 21 | 26 | 24 | 9 | -1 | 22 | 26 | 47 | 43 | 62 | 40 | 16 | -153 | -30 | 42 | 85 | 77 | 116 | 117 | 119 | 137 | 211 | 190 | 214 | 206 | 248 | 209 | 225 | 232 | 232 | 219 | 254 |
| Tax | 11 | 11 | 16 | 14 | 8 | 12 | 15 | 11 | 15 | 10 | 10 | 10 | -1 | 3 | 8 | 13 | 10 | 13 | 17 | 9 | 4 | -34 | -26 | 1 | 17 | 1 | 17 | 20 | 50 | 27 | 42 | 36 | 40 | 22 | 22 | 21 | 34 | 30 | 33 | 26 | 57 |
| Net Profit | -1 | -1 | 10 | 6 | 5 | 17 | 27 | 17 | 22 | 11 | 17 | 14 | 10 | -4 | 14 | 13 | 37 | 30 | 45 | 31 | 12 | -120 | -3 | 41 | 68 | 76 | 99 | 98 | 69 | 111 | 169 | 154 | 173 | 184 | 227 | 188 | 191 | 202 | 199 | 193 | 197 |
| EPS in ₹ | 0.00 | -0.03 | 0.52 | 0.29 | 0.25 | 0.85 | 1.31 | 0.84 | 1.10 | 0.54 | 0.82 | 0.70 | 0.48 | -0.21 | 0.67 | 0.63 | 1.83 | 1.49 | 2.23 | 1.55 | 0.59 | -5.90 | -0.17 | 2.01 | 3.35 | 3.75 | 4.89 | 4.80 | 3.40 | 5.45 | 8.31 | 7.57 | 8.53 | 9.06 | 11.16 | 9.26 | 9.39 | 9.92 | 9.78 | 9.50 | 9.71 |
Narayana Hrudayalaya
1,903.90
+0.80
(0.04%)
Market Cap
38,908.25 Cr
EPS
38.86
PE Ratio
48.82
Dividend Yield
0.24 %
Industry
Healthcare Services52 Week High
1,957.00
52 Week Low
1,171.00
PB Ratio
10.72
Debt to Equity
0.50
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from9 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,181.70 | #1 1,14,878.03 | 105.26 | 5,584.10 | 18.77 | #1 1,058 | 26.84 | 51.87 | |
6,933.50 | 99,693.09 | 69.66 | #1 19,165.50 | 14.74 | 917 | 60.41 | 49.02 | |
759.00 | 57,301.32 | 67.97 | 6,931.20 | 8.99 | 645 | -7.43 | 61.55 | |
1,903.90 | #4 38,908.25 | #1 48.82 | #4 5,093.40 | #9 10.96 | #3 790 | #6 3.41 | 67.31 | |
1,171.70 | 31,470.38 | 61.42 | 2,759.20 | #1 25.09 | 326 | -20.35 | 42.45 | |
569.70 | 28,457.26 | 79.35 | 3,723.70 | 22.85 | 205 | #1 3,986.36 | 54.57 | |
665.10 | 26,613.24 | 70.13 | 2,511.20 | 12.94 | 336 | 48.39 | 51.78 | |
1,458.90 | 14,815.37 | 60.62 | 1,566.90 | 17.46 | 244 | 10.57 | 58.44 | |
1,507.00 | 9,880.80 | 51.81 | 1,095.50 | 21.32 | 177 | -0.88 | 54.77 | |
539.20 | 7,517.28 | 169.72 | 1,929.10 | 12.97 | 41 | -71.06 | 42.11 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
10.96 %
Net Income Growth
30.17 %
Cash Flow Change
-1.66 %
ROE
-3.76 %
ROCE
-15.58 %
EBITDA Margin (Avg.)
7.25 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 |
| Fixed Assets | 913 | 1,055 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 |
| Current Assets | 260 | 286 | 302 | 479 | 527 | 586 | 665 | 909 | 1,294 | 1,946 |
| Capital Work in Progress | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 |
| Investments | 0 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 |
| Other Assets | 437 | 401 | 416 | 644 | 725 | 701 | 669 | 951 | 1,315 | 1,615 |
| Total Liabilities | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 |
| Current Liabilities | 343 | 315 | 323 | 510 | 510 | 602 | 703 | 780 | 987 | 1,110 |
| Non Current Liabilities | 258 | 365 | 361 | 989 | 1,045 | 1,153 | 946 | 861 | 1,042 | 1,629 |
| Total Equity | 769 | 876 | 963 | 1,036 | 1,082 | 1,137 | 1,121 | 1,489 | 2,132 | 2,885 |
| Reserve & Surplus | 568 | 674 | 761 | 833 | 878 | 933 | 917 | 1,286 | 1,928 | 2,681 |
| Share Capital | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -6 | 42 | 28 | -22 | 89 | 8 | -2 | 59 | -4 | 97 |
| Investing Activities | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 |
| Operating Activities | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 |
| Financing Activities | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 489 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 11.60 % | 0.00 % | 10.91 % | 10.01 % | 9.68 % | 9.44 % | 9.66 % |
| DIIs | 14.80 % | 15.55 % | 16.15 % | 14.61 % | 13.76 % | 13.43 % | 16.18 % | 14.58 % | 14.14 % | 11.95 % | 10.89 % | 9.46 % | 9.51 % | 8.23 % | 7.90 % | 8.69 % | 8.52 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 4.64 % | 4.97 % | 4.85 % | 5.11 % | 5.92 % | 6.87 % | 5.86 % | 6.93 % | 7.10 % | 7.99 % | 8.46 % | 9.04 % | 10.00 % | 11.68 % | 12.13 % | 11.58 % | 11.47 % |
| Others | 16.71 % | 15.63 % | 15.14 % | 16.43 % | 16.46 % | 15.85 % | 14.11 % | 14.64 % | 14.90 % | 16.20 % | 5.20 % | 17.65 % | 5.73 % | 6.23 % | 6.43 % | 6.43 % | 6.50 % |
| No of Share Holders | 0 | 36,360 | 44,526 | 43,565 | 43,807 | 52,747 | 65,173 | 68,130 | 75,370 | 86,631 | 1,02,994 | 1,20,506 | 1,38,052 | 1,60,686 | 1,78,356 | 1,77,792 | 1,85,787 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 | 1 | 2.5 | 4 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.4 | 0.25 | 0.00 | 0.13 | 0.19 | 0.24 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Aug 2025 |  Annual General Meeting | NA | 29 Aug 2025 | 1,724.30 | 1,902.60 |
| 23 May 2025 |  Quarterly Result Announcement | NA | 23 May 2025 | 1,790.70 | 1,724.30 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 1,372.70 | 1,329.00 |
| 31 Oct 2024 | Quarterly Result Announcement | NA | 31 Oct 2024 | 1,236.20 | 1,222.55 |
| 30 Aug 2024 | Annual General Meeting | NA | 30 Aug 2024 | 1,255.10 | 1,265.50 |
| 02 Aug 2024 |  Dividend | ₹ 4.00 /share | 02 Aug 2024 | 1,255.10 | 1,252.75 |
| 07 Jul 2023 | Dividend | ₹ 2.50 /share | 07 Jul 2023 | 767.85 | 1,012.95 |
| 23 Aug 2022 | Dividend | ₹ 1.00 /share | 22 Aug 2022 | 659.80 | 705.15 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Acquisition7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2025
Jun 04, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2025
Jun 02, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
May 27, 2025Clarification To The Volume Movement Letter Dated May 27 2025 Received From BSE Ltd.May 27, 2025
May 27, 2025Clarification sought from Narayana Hrudayalaya LtdMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
May 26, 2025General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.May 23, 2025
May 23, 2025General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.May 23, 2025
May 23, 2025Shareholders MeetingMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 23, 2025
May 23, 2025General Updates - Recommendation By The Board For The Issuance Of Non-Convertible Securities.May 23, 2025
May 23, 2025Record Date - For DividendMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 23, 2025
May 23, 2025Corporate Action-Board approves DividendMay 23, 2025
May 23, 2025Board Meeting Outcome for Outcome Of The Board Meeting For The Financial Results For The Quarter And Year Ended March 312025May 23, 2025
May 23, 2025Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025May 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2025
May 19, 2025Board Meeting Intimation for Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 Dividend And Fund RaisingMay 16, 2025
May 16, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-RevisedApr 30, 2025
Apr 30, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 14, 2025
Apr 14, 2025Rumour verification - Regulation 30(11)Apr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 05, 2025
Apr 05, 2025Intimation Regarding Agreement Between The Wholly Owned Subsidiary Of The Company- Narayana Vaishno Devi Specialty Hospitals Private Limited With Shri Mata Vaishnodevi Charitable SocietyMar 28, 2025
Mar 28, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Mar 18, 2025Regulation 30_Intimation Regarding The Execution Of Joint Venture Agreement By Health City Cayman Islands A Wholly Owned Subsidiary Of The Company.Mar 08, 2025
Mar 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 07, 2025
Mar 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 24, 2025
Feb 24, 2025Intimation Under Regulation 30 Read With Para B Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 20, 2025
Feb 20, 2025Rumour verification - Regulation 30(11)Feb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-AllotmentFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Feb 15, 2025Intimation Of Acquisition Of Shares By A Wholly-Owned Overseas Subsidiary Of The CompanyFeb 14, 2025
Feb 14, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Feb 14, 2025Technical Indicators
RSI(14)
Neutral 67.23
ATR(14)
Volatile 58.66
STOCH(9,6)
Overbought 82.82
STOCH RSI(14)
Overbought 82.24
MACD(12,26)
Bullish 16.11
ADX(14)
Strong Trend 33.19
UO(9)
Bearish 55.57
ROC(12)
Uptrend But Slowing Down 8.99
WillR(14)
Neutral -22.97
Mutual Fund Holdings
DSP Focus Direct Plan-Growth 
Mirae Asset Multicap Fund Direct - Growth 
Axis Momentum Fund Direct - Growth 
Union Active Momentum Fund Direct-Growth 
Shriram Multi Sector Rotation Fund Direct-Growth 
Nippon India Pharma Fund Direct-Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth 
HDFC Nifty Smallcap 250 Index Fund Direct-Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth 
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth 
Groww Nifty Smallcap 250 Index Fund Direct - Growth About Narayana Hrudayalaya
Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years,
12 days)
Chairperson NameDEVI PRASAD SHETTY
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
